Jeff Galecke, Managing Partner, i5 BioPartners | Onyx Live | ISCT Dublin 2026
The cell and gene therapy tools companies that scale aren't always the ones with the best technology, says i5 BioPartners' Jeff Galecke – they're the ones that can tell a clear story.